TL;DR: BAS 13029794 (CAS 878729-13-6) is a chemical compound with molecular formula C19H18ClN5O4 and molecular weight 415.10474 g/mol, supplied by CoreyChem (Career Henan Chemical Co., Ltd.) with ISO-certified quality and global shipping.
methyl 2-[6-(3-chloro-4-methylphenyl)-4,7-dimethyl-1,3-dioxopurino[7,8-a]imidazol-2-yl]acetate
Also Known As: BAS 13029794, VU0509552-1, F3124-0225, methyl 2-(8-(3-chloro-4-methylphenyl)-1,7-dimethyl-2,4-dioxo-1H-imidazo[2,1-f]purin-3(2H,4H,8H)-yl)acetate, methyl 2-[6-(3-chloro-4-methylphenyl)-4,7-dimethyl-1,3-dioxopurino[7,8-a]imidazol-2-yl]acetate
| Molecular Formula | C19H18ClN5O4 |
| Molecular Weight | 415.10474 g/mol |
| XLogP | 3.5 |
| Topological Polar Surface Area (TPSA) | 89.2 Ų |
| Hydrogen Bond Donors | 0 |
| Hydrogen Bond Acceptors | 5 |
| Rotatable Bonds | 4 |
| Exact Mass | 415.10474 Da |
| Heavy Atoms | 29 |
| Complexity | 708.0 |
| SMILES | CC1=C(C=C(C=C1)N2C(=CN3C2=NC4=C3C(=O)N(C(=O)N4C)CC(=O)OC)C)Cl |
| InChIKey | UCRWXTJLKXTQOC-UHFFFAOYSA-N |
The XLogP value of 3.5 indicates that BAS 13029794 is lipophilic (fat-soluble), which may influence its absorption, distribution, and formulation strategy. The TPSA of 89.2 Ų falls within the moderate polarity range, balancing permeability and solubility for BAS 13029794. Following Lipinski's Rule of Five, BAS 13029794 has 0 hydrogen bond donor(s) and 5 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
The CAS number of BAS 13029794 is 878729-13-6.
The molecular formula of BAS 13029794 is C19H18ClN5O4.
The molecular weight of BAS 13029794 is 415.10474 g/mol.
You can request a quote for BAS 13029794 directly from CoreyChem. Contact us or email [email protected] for pricing and availability.
Yes, CoreyChem provides custom synthesis services for BAS 13029794 and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.
Request a quote for CAS 878729-13-6. Our professional technical team will respond with pricing and lead time.